Author | Age | Sex | Site of primary disease | TNM stage | Treatment of primary disease | Timing of PEG placement (before or after primary therapy) | Time from PEG placement to stomal metastasis (months) | Other concurrent treatment failure sites | Treatment of PEG-site metastasis | Length of survival after PEG metastasis diagnosis (months) |
---|---|---|---|---|---|---|---|---|---|---|
Adelson[17] | 63 | M | Oropharynx | NA | Surgery | Before | 6 | Lung, liver | Chemo | 4 |
Ananth[3] | 55 | M | Oral Cavity | T1N2aM0 | Surgery + XRT | Before | 3.5 | NCR | Surgery + Chemo | NED |
Balakrishnan[18] | 50 | M | Larynx | NA | Surgery | Before | NA | NCR | Surgery | NA |
Becker[19] | 49 | M | Hypopharynx | T4N3M0 | XRT | Before | 3 | Lung | Surgery | 5 |
Bhama[20] | 51 | M | Hypopharynx | T2N1M0 | XRT | Before | 3.5 | Liver, pelvis | Surgery | 4 |
Bushnell[9] | 68 | M | Supraglottis | T4N2bM0 | Surgery + XRT | After | 14 | Lung | None | 18 |
Chatni[10] | 53 | F | Hypopharynx | NA | XRT | After | 5 | Neck | None | NA |
Coletti[21] | 65 | M | Oral Cavity | T4N2cM0 | ChemoXRT | Before | 9 | NCR | ChemoXRT | 2 |
Cossentino[22] | 62 | M | Oropharynx | T4N2M0 | Surgery + XRT | Before | 8 | Lung | None | 2 |
 | 66 | M | Oropharynx | T3N1M0 | XRT | Before | 9 | NA | None | NA |
Cruz[23] | 58 | M | Oral Cavity | T4N0M0 | XRT | Before | 5 | NA | Surgery + Chemo | 4 |
 | 48 | M | Hypopharynx | T4N3M0 | Surgery + ChemoXRT | Before | 6 | NA | Surgery | 4 |
Daniels[24] | 56 | M | Oral Cavity | TxN+M0 | Surgery + XRT | Before | 3 | NA | Chemo + Surgery | NA |
Douglas[15] | 45 | M | Oropharynx | T4N3M0 | XRT | Before | 3.5 | NCR | XRT | 9 |
Hawkin[8] | 68 | M | Oropharynx | T3N0M0 | XRT | Before | 14 | NCR | None | 1 |
Huang[25] | 53 | M | Oropharynx | T4N2aM0 | Surgery + XRT | Before | 6 | NA | NA | NA |
Kurdow[26] | 75 | F | Hypopharynx | T4N0M0 | XRT | Before | 4 | NA | NA | NA |
Laccourreye[11] | 65 | M | Hypopharynx | T3N0M0 | ChemoXRT | After | 11 | Liver | XRT | 4 |
Lee[27] | 41 | M | Oropharynx | T4N2bM0 | Surgery + ChemoXRT | Before | 13 | Liver, spleen | None | 1 |
Lim[28] | 51 | M | Oropharynx | T4N1M0 | Surgery + XRT | Before | 8 | Lung | Surgery | NA |
Lin[13] | 56 | M | Oropharynx | T4N0M0 | Surgery + XRT | Before | 5 | NCR | NA | 2 |
Maccabee[29] | 63 | F | Hypopharynx | T4N1M0 | ChemoXRT | Before | 5 | Primary site | None | 3 |
Meurer[30] | 45 | M | Oropharynx | T3N1M0 | Surgery | Before | 12 | Lung | ChemoXRT | 17 |
 | 76 | F | Oropharynx | T2N0M0 | XRT | Before | 13 | Lung | Surgery | 16 |
Mincheff[4] | 59 | M | Oropharynx | T4N2bM0 | Surgery + XRT | NA | 4 | NCR | Surgery + XRT | NA (Hospice) |
Potochny[31] | 44 | M | Hypopharynx | T2N2M0 | Surgery + XRT | Before | 9 | NCR | Surgery | NED |
Preyer[14] | 72 | M | Oropharynx | T4N2cM0 | ChemoXRT | Before | 3 | Lung | None | 3 |
Purandare[32] | 50 | F | Oropharynx | T3N2M0 | Surgery | NA | 9 | Primary site, neck | NA | NA |
 | 62 | M | Oral Cavity | T2N0M0 | Surgery | NA | 15 | Primary site | NA | NA |
Schiano[12] | 43 | M | Hypopharynx | T4NxM0 | Chemo | After | 4 | Primary site, neck | NA | NA |
Schneider[33] | 61 | F | Oropharynx | T4N0M0 | Surgery + XRT | Before | 10 | NCR | Surgery | NED |
Sharma[34] | 40 | M | Oral Cavity | T4N3M0 | ChemoXRT | Before | 6 | Primary site | Surgery + Chemo | NA (Hospice) |
Siddiqi[35] | 56 | F | Supraglottis | T3N2bM0 | ChemoXRT | Before | 7 | NA | NA | 2 |
Sinclair[36] | 61 | M | Oropharynx | T2N1M0 | XRT | Before | 5 | Left axilla | Surgery + ChemoXRT | NA (recurrent disease detected) |
Thakore[37] | 50 | M | Larynx | NA | Surgery + ChemoXRT | NA | NA | Lung, hip, brain | ChemoXRT | 6 |
Thorburn[38] | 56 | M | Supraglottis | T4N3M0 | XRT | Before | 11 | NA | NA | 1 |
Tucker[16] | NA | NA | Hypopharynx | NA | ChemoXRT | Before | 3 | NA | NA | NA |
Van erpecum[39] | 69 | M | Hypopharynx | T4N0M0 | XRT | Before | 10 | NCR | XRT + Surgery | 1 |
Current series | 69 | M | Hypopharynx | T2N2aM0 | ChemoXRT | Before | 22 | Adrenals, liver, lung | Chemo XRT | 8 |
 | 77 | M | Supraglottis | T3N1M0 | ChemoXRT | Before | 16 | NCR | Chemo | 5 |
 | 46 | M | Oral Cavity | T4N1M0 | ChemoXRT | Before | 8 | NCR | Surgery | 19 |
 | 64 | M | Oropharynx | T1N2cM0 | XRT | Before | 7 | Primary site, neck | Surgery | NED |
Total cases | 42 | Â | Â | Â | Â | Â | Â | Â | Â | Â |